This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Diagnosis  • Neoplasms  • Alert me on articles by topic

Agreement Between Observers

Alon Scope, MD; Stephen W. Dusza, MPH; Allan C. Halpern, MD, MS; Harold Rabinovitz, MD; Ralph P. Braun, MD; Iris Zalaudek, MD; Giuseppe Argenziano, MD; Ashfaq A. Marghoob, MD

Arch Dermatol. 2008;144(1):58-64.

Objectives  To assess whether multiple observers can identify the same pigmented lesion(s) as being different from a patient's other moles ("ugly duckling" [UD] sign) and to explore whether the UD sign is sensitive for melanoma detection.

Design  Baseline back images of 12 patients were obtained from a database of standardized patient images. All patients had at least 8 atypical moles on the back, and in 5 patients, one of the lesions was a histologically confirmed melanoma. The overview back images were supplemented with close-up clinical images of lesions. Participants were asked to evaluate whether the images showed any lesions on the back that differed from other nevi.

Setting  Dermatology clinic specializing in pigmented lesions.

Participants  Images were evaluated by 34 participants, including 8 pigmented lesion experts, 13 general dermatologists, 5 dermatology nurses, and 8 nonclinical medical staff.

Main Outcome Measures  A lesion was considered a generally apparent UD if it was perceived as different by at least two-thirds of the participants. Sensitivity was defined as the fraction of melanomas identified as different.

Results  All 5 melanomas (100%) and only 3 of 140 benign lesions (2.1%) were generally apparent as different. The sensitivity of the UD sign for melanoma detection was 0.9 for the whole group, 1.0 for experts, 0.89 for general dermatologists, 0.88 for nurses, and 0.85 for nonclinicians. A limitation of the study is that assessment was done in virtual settings.

Conclusions  In the present study, melanomas were generally apparent as UDs. The potential of the UD sign for melanoma screening should be further assessed.

Author Affiliations: Dermatology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York (Drs Scope, Halpern, and Marghoob and Mr Dusza); Skin and Cancer Associates, Plantation, Florida (Dr Rabinovitz); and Departments of Dermatology, University Hospital Zurich, Zurich, Switzerland (Dr Braun), Medical University of Graz, Graz, Austria (Dr Zalaudek), and Second University of Naples, Naples, Italy (Dr Argenziano).